TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹281 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹744 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 30.79 | |
| Mar2024 | ₹281 Cr | -59.20 | |
| Mar2023 | ₹688 Cr | 26.44 | |
| Mar2022 | ₹544 Cr | -26.83 | |
| Mar2021 | ₹744 Cr | - | |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹145,395.3 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
| MANKIND PHARMA | ₹83,401.6 Cr | 1% | -1.3% | -11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.1% |
-0.4% |
31.8% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses